Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis
Completed · Phase 3 · Has a placebo group
Conditions studied: Relapsing Multiple Sclerosis
In brief
The primary objective of this study is to determine the efficacy of peginterferon beta-1a in reducing the annualized relapse rate (ARR) in participants with relapsing multiple sclerosis (RMS) at 1 year. The secondary objectives of this study are to determine whether peginterferon beta-1a, at 1 year when compared with placebo, is effective in reducing the total number of new or newly enlarging T2 hyperintense lesions on brain magnetic resonance imaging (MRI) scans, reducing the proportion of participants who relapse, and slowing the progression of disability.
Key facts
- Study ID
- NCT00906399
- Run by
- Biogen
- People needed
- 1516
- Starts
- 2009-06-01
- Expected to finish
- 2013-10-01
- Last updated by the study team
- 2014-09-19
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Ponte Vedra Beach, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Des Moines, Iowa, United States
- Research Site — Lexington, Kentucky, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — Teaneck, New Jersey, United States
- Research Site — Raleigh, North Carolina, United States
- Research Site — Akron, Ohio, United States
- Research Site — Cleveland, Ohio, United States
- Research Site — Franklin, Tennessee, United States
- Research Site — Round Rock, Texas, United States
- Research Site — Brussels, Belgium
- Research Site — Sint-Truiden, Belgium
- Research Site — Plovdiv, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — London, Ontario, Canada
- Research Site — Montreal, Quebec, Canada
- Research Site — Santiago, Chile
- Research Site — Barranquilla, Atlántico, Colombia
- Research Site — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.